ValueMax Group Limited Announces Issuance of New Shares Following Warrant Exercise

ValueMax Group Limited has made a significant announcement regarding the increase in its share capital. The Board of Directors has confirmed that the company’s total issued ordinary shares have risen from 941,205,339 (excluding 100,000 treasury shares) to 941,789,339 ordinary shares. This increase comes as a result of the allotment and issuance of 584,000 new ordinary shares following the exercise of 584,000 warrants at an exercise price of S\$0.36 per warrant.

Key Points for Investors

• Share Capital Expansion: The exercise of warrants has led to a fresh injection of shares into the market, potentially increasing liquidity and altering the shareholding structure.
• Exercise Price: Each warrant was exercised at S\$0.36, which may offer insights into investor confidence and perceived value relative to the current market price.
• Listing Date: The new shares will be listed and quoted on the Singapore Exchange Securities Trading Limited (SGX-ST) on 12 February 2026.
• Outstanding Warrants: Following this exercise, there are still 6,015,970 outstanding warrants available, each with an exercise price of S\$0.36 and expiring at 5.00 p.m. on 14 September 2026.
• Share Rights: The newly issued shares will rank pari passu (i.e., equally) in all respects with existing shares, ensuring full rights and entitlements for new shareholders.

Potential Price Sensitivity and Impact

The increase in share capital through warrant exercise can have several implications for shareholders and the share price:

• Dilution Effect: The issuance of new shares may dilute the holdings of existing shareholders, potentially impacting earnings per share and voting rights.
• Market Sentiment: The fact that holders are exercising warrants at S\$0.36 could signal confidence in the company’s prospects, especially if the current share price exceeds the exercise price.
• Future Overhang: The existence of over 6 million outstanding warrants presents a potential future dilution risk should these be exercised, which investors should monitor as the expiry date approaches.
• Liquidity and Trading Activity: With more shares entering the market, liquidity may improve, but investors should watch for increased volatility around listing dates.

What Shareholders Should Know

Shareholders are advised to take note of the following:

• The precise number of new shares issued and the total shares in issue as of 10 February 2026.
• The exercise price of S\$0.36 as a reference point for future warrant exercises and possible market reactions.
• The listing date for the new shares (12 February 2026), which may see increased trading activity.
• Outstanding warrants and their expiry (14 September 2026), as these may continue to affect share capital and market dynamics.
• Equality of shares—the new shares will carry the same rights as existing shares.

Conclusion

This announcement is notable for its potential to affect both the share price and the shareholder structure of ValueMax Group Limited. Investors and shareholders should assess the dilution impacts, monitor warrant exercises, and stay alert to future announcements regarding outstanding warrants.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult with a licensed financial advisor before making any investment decisions. The information is based on company announcements as of the date specified and may be subject to change.

View ValueMax W260914 Historical chart here